Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Colorectal Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.

Jonathan Efron is a Colorectal Surgeon in Baltimore, Maryland. Dr. Efron is rated as an Elite provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Ileostomy, and Hernia Surgery.

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics. Dr. Le is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Ross C. Donehower is an oncologist in the Baltimore area, caring for patients with gastrointestinal cancers. He was part of the team that developed premedications that allowed paclitaxel — a chemotherapy medication now used to treat several types of cancers — to be safely given to patients. The Virginia and D.K. Ludwig Professor in Clinical Investigation of Cancer, he serves as the director of the Hematology & Medical Oncology Fellowship Program and director of the Division of Medical Oncology at the Johns Hopkins School of Medicine. Dr. Donehower received his undergraduate degree from Hamline University and earned his M.D. from the University of Minnesota. He completed his residency at The Johns Hopkins Hospital. Dr. Donehower joined the Johns Hopkins faculty in 1980. Prior to joining Johns Hopkins, Dr. Donehower was a surgeon with the U.S. Public Health Service and a clinical associate of the medicine branch and clinical pharmacology branch at the National Cancer Institute. His research interests include gastrointestinal cancers, new anticancer drug development and pharmacology. Dr. Donehower serves on the editorial boards of numerous scholarly journals, including the International Journal of Oncology. He has been recognized by the American Society of Clinical Oncology with a 2017 Excellence in Teaching Award. He is a member of several professional organizations, including the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Donehower is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Ilene S. Browner, M.D. specializes in geriatric oncology. Dr. Browner is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Endoscopy.

Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Eric Christenson is an Oncologist in Baltimore, Maryland. Dr. Christenson is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Cholangiocarcinoma (Bile Duct Cancer).

Joshua Levin is a General Surgeon and a Colorectal Surgeon in Bel Air, Maryland. Dr. Levin is rated as an Experienced provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, Rectal Prolapse, and Hernia Surgery. Dr. Levin is currently accepting new patients.

Dr. Vivek A. Patil is a colorectal surgeon affiliated with Sibley Memorial Hospital and Suburban Hospital, where he serves as chairman of colorectal surgery, as well as Shady Grove Adventist Hospital and Holy Cross Hospital. He practices out of Colorectal Surgery of Maryland and Washington, D.C., located in Bethesda, Maryland. Dr. Patil has an expertise minimally-invasive surgery, including laparoscopy and robotic surgery, to treat benign and malignant conditions of the colon and rectum. He has special interests in anorectal conditions, inflammatory bowel disease and pelvic floor disorders. Dr. Patil earned his medical degree from Georgetown University School of Medicine. He completed a residency in general surgery at Lenox Hill Hospital, where he participated in surgical research and received the John O. Vieta, M.D. Award for Surgical Excellence and Compassionate Care. Dr. Patil also completed a fellowship in colorectal surgery at Washington Hospital Center. Dr. Patil is a fellow of the American College of Surgeons and the American Society of Colon and Rectal Surgeons. Dr. Patil has been consistently named one of Washingtonian Magazine’s Top Doctors. Dr. Patil is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Hemorrhoids, Rectal Prolapse, Colorectal Cancer, Hemorrhoidectomy, and Ileostomy.

Yudhishtra Markan is a Hematologist Oncology specialist and an Oncologist in Glen Burnie, Maryland. Dr. Markan is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

Brian Bello is a Colorectal Surgeon in Olney, Maryland. Dr. Bello is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Bladder Reconstruction, and Ureteroscopy.

Faisal Adhami is a Hematologist Oncology specialist and a Hematologist in Elkton, Maryland. Dr. Adhami is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Childhood Iron Deficiency Anemia, and Melanoma.

Susan Gearhart is a General Surgeon in Baltimore, Maryland. Dr. Gearhart is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. Her top areas of expertise are Rectal Prolapse, Colorectal Cancer, Bowel Incontinence, Ileostomy, and Colostomy.

Steven Proshan is a General Surgeon in Annapolis, Maryland. Dr. Proshan is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Mesenteric Venous Thrombosis, Hernia Surgery, and Colostomy.

Chady Atallah is a General Surgeon in Baltimore, Maryland. Dr. Atallah is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Anal Cancer, Colonoscopy, and Osteotomy.

Syed Nasir is a Hematologist and an Oncologist in Towson, Maryland. Dr. Nasir is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast.

Petr Hausner is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Hausner is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, and Anal Cancer. Dr. Hausner is currently accepting new patients.

Gang Chen is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Paget Disease of the Breast, and Hepato-Pancreato-Biliary Surgery. Dr. Chen is currently accepting new patients.

Blanche Mavromatis is an Oncologist in Cumberland, Maryland. Dr. Mavromatis is rated as an Advanced provider by MediFind in the treatment of Colorectal Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Mavromatis is currently accepting new patients.